Bioversys Ag
Clinical trials sponsored by Bioversys Ag, explained in plain language.
-
New drug duo takes on deadly brain infection
Disease control Not yet recruitingThis study tests a new two-drug combination (Alpibectir and Ethionamide) added to standard treatment for tuberculosis meningitis, a serious brain infection. About 64 adults newly diagnosed with the condition will receive the drugs to see how well they reach the brain and how safe…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New weapon against superbug pneumonia and blood infections
Disease control Not yet recruitingThis study tests a new antibiotic combination (BV100 plus other drugs) against hard-to-treat infections like pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. About 120 adults in the hospital will receive either the new combo or the best…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC